<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-153462</identifier>
<setSpec>1699-258X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pharmacogenetics of methotrexate</dc:title>
<dc:description xml:lang="en">Methotrexate is the drug of choice in the first-line treatment of patients with rheumatoid arthritis. In the last few decades, there has been strong interest in identifying pharmacogenetic markers that could accurately and reliably predict the effectiveness and toxicity of methotrexate. Several studies have suggested that the genes involved in the metabolic pathway of folic acid (MTHFR, DHFR, ATIC and TS) and the intraand extracellular methotrexate transport (RFC1/SLC19A1, ABCB1, FPGS and GGH) could play a role in predicting response to methotrexate, as well the toxicity of the drug (AU)</dc:description>
<dc:creator>Baiget, Montserrat</dc:creator>
<dc:creator>Moya, Patricia</dc:creator>
<dc:creator>Salazar, Juliana</dc:creator>
<dc:creator>Corominas, Héctor</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El metotrexato es el fármaco de elección en primera línea de tratamiento para pacientes con artritis reumatoide. En las últimas décadas ha habido un gran interés para identificar marcadores farmacogenéticos que puedan predecir con exactitud y fiabilidad la eficacia y toxicidad del metotrexato. Diferentes estudios han sugerido que los genes que participan en la vía metabólica del ácido fólico (MTHFR, DHFR, ATIC y TS) y el transporte intra y extraceluar del metotrexato (RFC1/SLC19A1, ABCB1, FPGS y GGH) pueden tener un potencial predictor de respuesta y toxicidad en el uso de metotrexato (AU)</dc:description>
<dc:source>Reumatol. clín. (Barc.);11(supl.1): 8-15, ene. 2016. tab, ilus</dc:source>
<dc:identifier>ibc-153462</dc:identifier>
<dc:title xml:lang="es">Farmacogenética del metotrexato</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d630^s22073</dc:subject>
<dc:subject>^d23433^s22073</dc:subject>
<dc:subject>^d22164^s22033</dc:subject>
<dc:subject>^d54079^s22002</dc:subject>
<dc:subject>^d22164^s22021</dc:subject>
<dc:subject>^d10788^s22066</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28169^s22065</dc:subject>
<dc:subject>^d10788^s22045</dc:subject>
<dc:subject>^d28169^s22078</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d10788^s22039</dc:subject>
<dc:subject>^d38209^s22065</dc:subject>
<dc:subject>^d38209^s22002</dc:subject>
<dc:subject>^d14327^s22065</dc:subject>
<dc:subject>^d14327^s22073</dc:subject>
<dc:subject>^d1178^s22057</dc:subject>
<dc:subject>^d38209^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201601</dc:date>
</metadata>
</record>
</ibecs-document>
